about
Nutritional therapies for mental disordersThe role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis)The role of long chain fatty acids and their epoxide metabolites in nociceptive signalingUnderstanding nutrition, depression and mental illnessesOptimization of the viability of stem cells derived from umbilical cord blood after maternal supplementation with DHA during the second or third trimester of pregnancy: study protocol for a randomized controlled trialOmega-3 supplementation lowers inflammation and anxiety in medical students: a randomized controlled trialTreatment options for nonalcoholic Fatty liver diseaseEffects of feeding sunflower oil or seal blubber oil to horses with recurrent airway obstruction.Monitoring blood glucose levels in female mink during the reproductive cycle: 2. Effects of short-term fish oil, chromium picolinate, and acetylsalicylic acid supplementation during late lactation.NMR protocol for determination of oxidation susceptibility of serum lipids and application of the protocol to a chocolate study.Effect of flaxseed on the fatty acid profile of egg yolk and antioxidant status of their neonatal offspring in Huoyan geese.Effect of Nutritionally Relevant Doses of Long-Chain N-3 Pufa on Lipid Status, Oxidative Stress and Inflammatory Markers in an Average Middle-Aged Serbian Population.Antioxidant potential of a polyherbal antimalarial as an indicator of its therapeutic value.Omega-3 Fatty Acids Supplementation Differentially Modulates the SDF-1/CXCR-4 Cell Homing Axis in Hypertensive and Normotensive Rats.Are Polyunsaturated Fatty Acid Metabolites, the Protective Effect of 4-hydroxytyrosol on Human Red Blood Cell Membranes and Oxidative Damage (4-hydroxyalkenals) Compatible in Hypertriglyceridemic Patients?Biological and Clinical Aspects of an Olive Oil-Based Lipid Emulsion-A Review.
P2860
Q21245899-9C78D49A-4BE1-4B60-AFED-F1DB2879CFE1Q24649593-A369ECC4-018C-4E56-AF8A-BD6443E7A69CQ28248377-008100B7-A0E7-4F37-9908-C1CE796525AAQ28258040-E256E1A3-565C-4F11-9110-E937F08FB6DEQ33624406-5366F5CC-91F6-47ED-83BE-36DAEE0FD0C7Q34027819-600BD381-A53C-415D-8325-1E0EBBD86806Q34156317-4256712D-7340-4708-BE91-7087400E3D82Q35129549-82E540F1-2C56-4296-8187-A6A3337009A7Q35925711-971B00F0-CDEB-4323-9FD9-6B5AEE800511Q35957631-2478DFFA-B711-4D2F-9C53-80EB2D0DC5F8Q36174703-2D07D6DE-DFCF-43CA-844C-018CC240466EQ37041281-9DE18CCB-B5F3-4417-B480-11ED29DCAD82Q37433146-C38DF2E3-3B05-4198-A480-A2AD8C13EAD7Q41583929-2B797C76-A523-4563-80AB-D2072A128920Q46260708-E2F8218C-593F-4E7B-8240-E696343B4C2DQ55515234-E5ABE981-762A-4D69-A5F8-F609526AE600
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Safety considerations of polyunsaturated fatty acids.
@ast
Safety considerations of polyunsaturated fatty acids.
@en
type
label
Safety considerations of polyunsaturated fatty acids.
@ast
Safety considerations of polyunsaturated fatty acids.
@en
prefLabel
Safety considerations of polyunsaturated fatty acids.
@ast
Safety considerations of polyunsaturated fatty acids.
@en
P356
P1476
Safety considerations of polyunsaturated fatty acids.
@en
P2093
Eritsland J
P304
P356
10.1093/AJCN/71.1.197S
P407
P433
P577
2000-01-01T00:00:00Z